Xenotransplantation of cryopreserved ovarian tissue from patients with ovarian tumors into SCID mice—no evidence of malignant cell contamination Laura Lotz, Markus Montag, Ph.D., Hans van der Ven, M.D., Michael von Wolff, M.D., Andreas Mueller, M.D., Inge Hoffmann, David Wachter, M.D., Matthias W. Beckmann, M.D., Ralf Dittrich, Ph.D. Fertility and Sterility Volume 95, Issue 8, Pages 2612-2614.e1 (June 2011) DOI: 10.1016/j.fertnstert.2011.05.003 Copyright © 2011 American Society for Reproductive Medicine Terms and Conditions
Supplemental Figure 1 Histologic and immunohistochemical analysis of ovarian tissue from patients with ovarian tumors recovered from mice after 24 weeks’ grafting. (A) Ovarian grafts with follicles. (B) 1 tertiary follicle stained with hematoxylin and eosin (original magnification: ×50 and ×200). (C) Ovarian grafts with follicles. (D) 1 tertiary follicle stained with antibodies against pancytokeratin (monoclonal antibody KL1; original magnification: ×50 and ×200). Fertility and Sterility 2011 95, 2612-2614.e1DOI: (10.1016/j.fertnstert.2011.05.003) Copyright © 2011 American Society for Reproductive Medicine Terms and Conditions